Leon Wang

CFO

Analyst

Barclays

Equibles does not estimate personal net worth.

Get an email with a short summary when Astrazeneca PLC publishes a filing, an earnings call transcript or a press release.

Get AZN alerts

About Leon Wang

Leon Wang is recorded as CFO at Astrazeneca PLC (AZN) and Analyst at Barclays. Leon Wang has spoken on 1 earnings call across 1 company, most recently for Gilead Sciences, Inc. on February 6, 2024. Astrazeneca PLC is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other companies whose calls Leon Wang spoke on are classified in the Healthcare sector.

Leon Wang on recent calls

“So at this point, what conviction do you have a needle cell will differentiate on neurotox or Parkinsonism versus your competitors, and if the lack of neurotox data recapitulate later this year, would that be the risking in your view, and how important would that be in the market?”

Analyst — Barclays, Gilead Sciences, Inc. Q4 FY2023 Earnings Call · February 6, 2024